Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Signal weather
The story has moved beyond the first headline and now acts as a reliable context anchor.
Why now
This story is still moving and pulling follow-up coverage.